QA: Chemours Co in us_medicinal_products/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001627223_2018_Chemours_Co.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001627223, Chemours Co

  xvar xval
0 LiabilitiesNoncurrent 4,572,000,000
1 LiabilitiesCurrent 1,648,000,000
2 remainder_Liabilities 208,000,000
3 AssetsCurrent 3,493,000,000
4 AssetsNoncurrent 626,000,000
5 PropertyPlantAndEquipmentNet 3,008,000,000
6 Goodwill 0
7 remainder_Assets 166,000,000
8 GeneralAndAdministrativeExpense 602,000,000
9 ResearchAndDevelopmentExpense 80,000,000
10 remainder_Expenses 4,866,000,000
11 remainder_Revenues 6,183,000,000
12 remainder_NetIncome 112,000,000
13 remainder_ComprehensiveNetIncome 134,000,000
  yvar yval
0 Liabilities 6,428,000,000
1 Assets 7,293,000,000
2 Expenses 5,548,000,000
3 Revenues 6,183,000,000
4 StockholdersEquity 865,000,000
5 NetIncome 747,000,000
6 ComprehensiveNetIncome 814,000,000
7 BaseVar 12,849,000,000
8 EconomicCapitalRatio 0.226

Edgar->Model Mapping

Feature Distribution

Change over Time